NSCLC without actionable oncogenic alterations

Details

Files
Project Status:
Complete
Therapeutic Area:
Unmutated Non-small cell lung cancer
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0012-000

Review Type: Rapid

Provisional Funding Algorithm

Draft Report Posted: June 23, 2022
Stakeholder Feedback Deadline: June 30, 2022
Final Report Posted: August 5, 2022